SYNTHESIS AND BIOLOGICAL ACTIVITIY OF 1H-1,2,4-TRIAZOLE ALCOHOL DERIVATIVES
649
1
169◦C; H NMR δ (300 MHz, CDCl3): 3.44 (s, 3H, OCH3),
3.95 (s, 2H, C5H4), 4.13 (s, 5H, C5H4), 4.35 (s, 2H, C5H4), 5.03
(s, 2H, CH2), 5.65 (s, 1H, CH), 6.68(s, 1H, =CH), 7.31–7.78
(m, 4H, ArH), 7.96 (s, 1H, TrH), 8.03 (s, 1H, TrH); EI-MS
(M+) m/z: 447. Anal. Calcd. for C23H22ClFeN3O: C 61.70, H
4.95, N 9.38. Found: C 62.01, H 5.13, N 9.63.
4d: 2-((1H-1,2,4-Triazol-1-yl)methyl)-3-ferrocenyl-1-(2,5-
dichlorophenyl) prop-2-en-1-ol. Yield 68.2%; yellow solid; m.p.
167–168◦C; 1H NMR δ (300 MHz, CDCl3): 4.08 (s, 5H, FcH),
4.23 (s, 2H, FcH), 4.28 (s, 2H, FcH), 4.92 (d, d, J = 14.1 Hz,
2H, CH2), 5.59 (d, J = 3.3 Hz, 1H, CH), 6.63 (s, 1H, =CH),
7.23 (d, J = 2.4 Hz, 1H, PhH), 7.03 (s, 1H, PhH), 7.71 (d, J =
2.4 Hz, 1H, PhH), 8.00 (s, 1H, TrH), 8.08 (s, 1H, TrH); EI-MS
(M+) m/z: 467. Anal. Calcd. for C22H19Cl2FeN3O: C 56.44,
H 4.09, N 8.99. Found: C 56.17, H 3.94, N 9.04.
5k: 1-(2-((4-Fluorophenyl(methoxy)methyl)-3-(ferrocenyl)
allyl-1H-1,2,4-triazole. Yield 24.6%; yellow solid; m.p. 145–
1
147◦C; H NMR δ (300 MHz, CDCl3): 3.46 (s, 3H, OCH3),
4e: 2-((1H-1,2,4-Triazol-1-yl)methyl)-3-ferrocenyl-1-(3-
chlorophenyl) prop-2-en-1-ol. Yield 74.2%; yellow solid; m.p.
160–162◦C; 1H NMR δ (300 MHz, CDCl3): 3.88 (s, 1H, OH),
4.02 (s, 5H, FcH), 4.23 (s, 4H, FcH), 4.90 (d, d, J = 14.1 Hz, 2H,
CH2), 5.61 (s, 1H, CH), 6.60 (s, 1H, =CH), 7.19–7.25 (m, 3H,
PhH), 7.66 (s, 1H, PhH), 7.90 (s, 1H, TrH), 7.98 (s, 1H, TrH);
EI-MS (M+) m/z: 433. Anal. Calcd. for C22H20ClFeN3O: C
60.92, H 4.65, N 9.69. Found: C 61.19, H 4.43, N 9.78.
4f: 2-((1H-1,2,4-Triazol-1-yl)methyl)-3-ferrocenyl-1-(2,4-
dichlorophenyl) prop-2-en-1-ol. Yield 69.1%; yellow solid; m.p.
172–174◦C; 1H NMR δ (300 MHz, CDCl3): 4.09 (s, 5H, FcH),
4.25 (s, 2H, FcH), 4.30 (s, 2H, FcH), 4.96 (d, d, J = 14.1 Hz,
2H, CH2), 5.61 (d, J = 3.3 Hz, 1H, CH), 6.67 (s, 1H, =CH),
7.25 (d, J = 2.4 Hz, 1H, PhH), 7.03 (s, 1H, PhH), 7.77 (d, J =
2.4 Hz, 1H, PhH), 8.02 (s, 1H, TrH), 8.10 (s, 1H, TrH); EI-MS
(M+) m/z: 467. Anal. Calcd. for C22H19Cl2FeN3O: C 56.44,
H 4.09, N 8.99. Found: C 56.17, H 3.94, N 9.04. Found: C 56.38,
H 3.77, N 8.96.
4g: 2-((1H-1,2,4-Triazol-1-yl)methyl)-3-ferrocenyl-1-(2-
chlorophenyl) prop-2-en-1-ol. Yield 76.1%; yellow solid;
168–170◦C; 1H NMR δ (300 MHz, CDCl3): 3.94 (s, 1H, OH),
4.08 (s, 5H, FcH), 4.27 (s, 4H, FcH), 4.92 (d, d, J = 14.1 Hz,
2H, CH2), 5.67 (s, 1H, CH), 6.66 (s, 1H, =CH), 7.21–7.37 (m,
3H, PhH), 7.68 (d, J = 7.5 Hz, 1H, PhH), 7.94 (s, 1H, TrH),
8.00 (s, 1H, TrH); EI-MS (M+) m/z: 433. Anal. Calcd. for
C22H20ClFeN3O: C 60.92, H 4.65, N 9.69. Found: C 61.20, H
4.44, N 10.08.
3.96 (s, 2H, C5H4), 4.15 (s, 5H, C5H4), 4.36 (s, 2H, C5H4),
5.07 (s, 2H, CH2), 5.69 (s, 1H, CH), 6.72 (s, 1H, =CH), 7.23–
7.30 (m, 2H, ArH), 7.79–7.85 (m, 2H, ArH), 7.99 (s, 1H, TrH),
8.06 (s, 1H, TrH); EI-MS (M+) m/z: 431. Anal. Calcd. for
C23H22FFeN3O: C 64.05, H 5.14, N 10.05. Found: C 64.33, H
5.40, N 9.63.
5l: 1-(2-((2,4-Dichlorophenyl(methoxy)methyl)-3-(ferroce
nyl)allyl-1H-1,2,4-triazole. Yield 27.0%; yellow solid; m.p.
145–147◦C; 1H NMR δ (300 MHz, CDCl3): 3.48 (s, 3H, OCH3),
3.97 (s, 2H, C5H4), 4.19 (s, 5H, C5H4), 4.45 (s, 2H, C5H4), 5.09
(s, 2H, CH2), 5.73 (s, 1H, CH), 6.75(s, 1H, =CH), 7.41–7.80
(m, 3H, ArH), 8.01 (s, 1H, TrH), 8.07 (s, 1H, TrH); EI-MS
(M+) m/z: 481. Anal. Calcd. for C23H21Cl2FeN3O: C 64.84,
H 4.74, N 9.41. Found: C 65.11, H 4.98, N 9.65.
RESULTS AND DISCUSSION
Synthesis
The intermediates 3 were prepared according to the
literature.[27] Title compounds 4 were prepared by reducing
intermediates 3 using NaBH4 as reducing agent in CH3OH
with yields of 70–80%. Compounds 4 were purified by sil-
ica gel column chromatography or by recrystallizing from
AcOEt/petroleum ether (60–90◦C) (V/V = 1/3). An unexpected
compound, 5i, the hydroxyl of the compound 4c being methy-
lated by methanol, was attained when we separated 4c with sil-
ica gel column chromatography. In order to investigate whether
another reaction could also produce a methylated product, we
studied the reaction further, and we found that when the ben-
zene cycle contains a donor group, the reaction can be isolated
to attain a methylated product. The reason may be the forma-
tion of C+ under the effect of concentrated hydrochloric acid
(Scheme 2). As the donor effect of the substituted group on the
benzene cycle can stabilize the C+, the title compounds that the
benzene cycle contain donor group can be methylated easily by
the resolution CH3OH.
4h: 2-((1H-1,2,4-Triazol-1-yl)methyl)-3-ferrocenyl-1-(3-
bromophenyl) prop-2-en-1-ol. Yield 67.2%; yellow solid; m.p.
166–167◦C; 1H NMR δ (300 MHz, CDCl3): 3.75 (s, 1H, OH),
4.06 (s, 5H, FcH), 4.21 (s, 4H, FcH), 4.92 (d, d, J = 12.6 Hz, 2H,
CH2), 5.60 (s, 1H, CH), 6.63 (s, 1H, =CH), 7.22–7.28 (m, 3H,
PhH), 7.47 (s, 1H, PhH), 7.90 (s, 1H, TrH), 7.99 (s, 1H, TrH);
EI-MS (M+) m/z: 477. Anal. Calcd. for C22H20BrFeN3O: C
55.26; H 4.22, N 8.79. Found: C 55.48, H 4.52, N 8.59.
5i: 1-(2-((2-Bromophenyl (methoxy)methyl)-3-(ferrocenyl)
allyl)-1H-1,2,4-triazole. Yield 26.3%; yellow solid; m.p. 163–
1
165◦C; H NMR δ (300 MHz, CDCl3): 3.42 (s, 3H, OCH3),
Biological Activities
3.94 (s, 2H, C5H4), 4.09 (s, 5H, C5H4), 4.29 (s, 2H, C5H4), 4.98
Title compounds 4 and unexpected compounds 5 were
(s, 2H, CH2), 5.62 (s, 1H, CH), 6.65 (s, 1H, =CH), 7.18–7.69 screened for their biological activities in vitro against
(m, 4H, ArH), 7.95 (s, 1H, TrH), 8.01 (s, 1H, TrH); EI-MS Gibberella zeae, Alternaria solani, Cercospora rachidicola,
(M+) m/z: 491. Anal. Calcd. for C23H22BrFeN3O: C 56.13, H Physalospora piricola, Phoma asparagi, Cladosporium cuc-
4.51; N 8.54. Found: C 56.82, H 4.60, N 8.64.
umerinum, Sclerotinia sclerotiorum, and Pyricularia oryzae at
5j: 1-(2-((3-Chlorophenyl(methoxy)methyl)-3-(ferrocenyl) a concentration of 50 µg/L, and the relative inhibitory ratios
allyl-1H-1,2,4-triazole. Yield 31.1%; yellow solid; m.p. 167– (%) against these fungi are listed in Table 1 The screening data